Last reviewed · How we verify
NCT03827005
L-arginine Supplementation and Resistance Exercise
NA trial testing L-arginine in Healthy Adult in 30 participants. Completed in 30 May 2017.
30 April 2017
Quick facts
| Lead sponsor | North Dakota State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 16 July 2016 |
| Primary completion | 30 April 2017 |
| Estimated completion | 30 May 2017 |
Drugs / interventions tested
- L-arginine — full drug profile →
- Placebo
Conditions studied
- Healthy Adult — all drugs for Healthy Adult →
Sponsor
North Dakota State University
Who can join
Adults 18 to 25, any sex, with Healthy Adult. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study was to examine the acute endothelial, cardiovascular, and performance responses to L-arginine by assessing flow-mediated dilation (FMD) and heart rate variability (HRV) both before and after resistance exercise to fatigue. Thirty (15 male, 15 female) physically active participants volunteered for a randomized, cross-over, double-blind, placebo- controlled clinical trial. Participants completed five sets of elbow extension-flexion exercise after consumption of either 3 g of placebo or 3 g L-arginine.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03827005
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of L-arginine
Trials testing the same drug.
- NCT06405477 — EFFECTS OF L-ARGININE SUPPLEMENTATION ON THE RECOVERY OF CARDIORESPIRATORY PARAMETERS AFTER SUBMAXIMAL EXERCISE TEST · NA · recruiting
- NCT05932979 — Effect of the Administration of L-arginine vs. Placebo in Patients Diagnosed With Presbyvestibulopathy. · Phase 2 · withdrawn
- NCT04535427 — Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis · Phase 2 · unknown
- NCT04054973 — L-arginine Study for Persistent Symptoms of Schizophrenia · Phase 2 · withdrawn
- NCT03665116 — Effects of Dietary Supplement on Osteoarthritis · NA · unknown
Other recruiting trials for Healthy Adult
Currently open trials in the same condition.
- NCT07361406 — SweetSpot - The Effect of Non-nutritive Sweeteners on Health · NA · recruiting
- NCT07393841 — Molecular Indicators of Systematic Fitness · recruiting
- NCT07343245 — A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs · Phase 1 · recruiting
- NCT07414862 — The Effects of Finger Extensor Training on Climbing Performance Compared With Traditional Flexor Training · NA · active not recruiting
- NCT07527247 — Improving Vaccine Protection for Older Adults · Phase 2 · recruiting
Other North Dakota State University trials
Trials by the same sponsor.
- NCT05396196 — An Analysis of Kinesio® Tape With Manual Fascial Glide Application on Trigger Points in The Iliotibial Band · NA · completed
- NCT05395572 — The Effects of Kinesio® Tape on Neck Pain and Disability · NA · completed
- NCT04769063 — An Analysis of Kinesio® Tape on Mitigation of Dynamic Knee Valgus · NA · completed
- NCT04461184 — The Great Plains Internet Wellness Study for Aging · NA · completed
- NCT04531306 — An Analysis of Kinesio® Tape on Myofascial Pain Syndrome of the Iliotibial Band · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03827005 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by North Dakota State University
- Last refreshed: 1 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03827005.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing